PRRT2 and Intellectual disability: According to the literature, 52.4% of patients carrying homozygous PRRT2 truncation mutations have intellectual disabilities, whereas only 0.6% of patients with heterozygous mutations have these symptoms,2 suggesting a gene‐dosage‐dependence of PRRT2 in intellectual development.